Phase 3 Unresectable Hepatocellular Carcinoma Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD.108 enrolled11 locationsNCT06900543
Recruiting
Phase 3
TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular CarcinomaApatinibCamrelizumab+1 more
Guohui Xu101 enrolled1 locationNCT06485466